Beta-2-microglobulin (β2M) loss is rarely found in distant metastases or dMMR adenomas and has been associated with improved prognosis, particularly adding prognostic value to the increased CD8+ T cell levels found in LS-CRC [77, 82, 83]. This evidence concerns the gene CD8A and Leigh syndrome.